<DOC>
	<DOCNO>NCT02331433</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , pharmacokinetics APN1125 administer single dos healthy adult subject .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Single Doses APN1125 Healthy Normal Subjects</brief_title>
	<detailed_description>The study consist 2 part : ( 1 ) single dose healthy adult volunteer , ( 2 ) effect food upon pharmacokinetics single dose APN1125 healthy adult volunteer .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Healthy male female Aged 18 65 year , inclusive Body mass index ( BMI ) 18 32kg/m^2 inclusive Screening Nonsmoker tobacco/nicotine usage 30 day Screening Personal family history neurological , cardiovascular , renal , hepatic , metabolic , gastrointestinal endocrine abnormality Any clinical abnormality cardiovascular ( e.g. , blood pressure ) electrocardiogram ( ECG ) parameter Screening checkin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>